← Leaderboards
Eoin P Flanagan
Mayo Clinic Rochester
$1,726,490
Attributed
$1,726,490
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $348K · FY2020–24$500K$375K$250K$125K$0
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$1,726,490 · 1
By mechanism
R01$1,726,490 · 1
Top collaborators
No co-investigators on record.
Most similar at Mayo Clinic Rochester
Same institution · by research overlap
- Lichun Lu$5,236,018
- Sean Joseph Pittock$1,682,764
- Irene G Sia$1,692,820
- Mark L. Wieland$4,969,420
Others in their field
Other Emerging Leaders on “Demyelinations”
- Dimitry N Krementsov · University Of Vermont & St Agric College$3,872,525
- David Pitt · Yale University$3,508,498
- Fraser James Sim · State University Of New York At Buffalo$3,430,826
- Deqiang Qiu · Emory University$3,221,061
- Daniel Ontaneda · Cleveland Clinic Lerner Com-Cwru$2,994,181
- Stephen Philip James Fancy · University Of California, San Francisco$2,932,733
Research focus
DemyelinationsDemyelinating DiseasesDecision MakingBiobankBiological MarkersAquaporin 4BlindnessAcute Disseminated EncephalomyelitisCellsCerebrospinal FluidCharacteristicsChildBlindClinicClinical Laboratory Improvement AmendmentsClinical PracticeCase StudyAntibodiesClinical Trials DesignCohortComaComplementComplement InactivatorsDependence
Grant awards (5)
Myelin oligodendrocyte glycoprotein antibody disease: incidence, prevalence, outcome prediction and immunopathology$334,781
R01 · FY2024 · NS · contact PI
Myelin oligodendrocyte glycoprotein antibody disease: incidence, prevalence, outcome prediction and immunopathology$348,005
R01 · FY2023 · NS · contact PI
Myelin oligodendrocyte glycoprotein antibody disease: incidence, prevalence, outcome prediction and immunopathology$347,907
R01 · FY2022 · NS · contact PI
Myelin oligodendrocyte glycoprotein antibody disease: incidence, prevalence, outcome prediction and immunopathology$347,907
R01 · FY2021 · NS · contact PI
Myelin oligodendrocyte glycoprotein antibody disease: incidence, prevalence, outcome prediction and immunopathology$347,890
R01 · FY2020 · NS · contact PI